Global Statistics

All countries
180,776,255
Confirmed
Updated on June 25, 2021 4:32 am
All countries
163,703,413
Recovered
Updated on June 25, 2021 4:32 am
All countries
3,916,246
Deaths
Updated on June 25, 2021 4:32 am

Global Statistics

All countries
180,776,255
Confirmed
Updated on June 25, 2021 4:32 am
All countries
163,703,413
Recovered
Updated on June 25, 2021 4:32 am
All countries
3,916,246
Deaths
Updated on June 25, 2021 4:32 am

Serum Institute will also produce Sputnik V, DCGI approves

Digital Desk, New Delhi. The Drug Controller General of India (DCGI) has given approval to Serum Institute of India to manufacture the Sputnik V vaccine. Serum Institute had applied for test, analysis and examination to DCGI on Wednesday. DGCA has given this approval to Serum Institute at their licensing facility at Hadapsar, Pune, subject to certain conditions. Currently, Sputnik-V is also being manufactured in India by Dr Reddy’s Laboratories.

The Pune-based company has collaborated with Gamalya Research Institute of Epidemiology and Microbiology, Moscow in Russia to develop Sputnik V in India.

Serum Institute of India is already producing the Oxford AstraZeneca Covid-19 vaccine named ‘Covishield’ and has told the government that it will supply 100 million doses of it in June. Serum Institute is also manufacturing the Novavax vaccine, which is awaiting regulatory approval from the US.

Russia’s Sputnik V was approved for emergency use by DCGI in April. SII is the sixth pharmaceutical company after Hetero Biopharma, Gland Pharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech to manufacture Sputnik V in India. Meanwhile, Hyderabad-based Dr Reddy’s Laboratories has tied up with Russian Direct Investment Fund to sell the first 250 million imported voids of Sputnik V in India.

The imported dosages are priced at Rs 995.40 per dose and Dr Reddy’s has indicated that the prices will come down once the local supply resumes. The first consignment of Sputnik vaccines made in India got clearance from Central Drug Laboratory, Kasauli on Tuesday. Sputnik is now registered in more than 50 countries. According to a study, the efficacy of this vaccine (both doses) is 97.6 percent.

.



Source link

Leave a Reply

spot_imgspot_img
spot_img

Hot Topics

Related Articles

You cannot copy content of this page
%d bloggers like this: